Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL
ClinicalTrials.gov study NCT03259529. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
ClinicalTrials.gov study NCT01043172. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary
ClinicalTrials.gov study NCT02590055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
ClinicalTrials.gov study NCT00042679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
ClinicalTrials.gov study NCT00658593. IPD Sharing: NO. Countries: 1. Publications: 0.
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
ClinicalTrials.gov study NCT05616624. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer
ClinicalTrials.gov study NCT00281996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology
ClinicalTrials.gov study NCT03703089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
ClinicalTrials.gov study NCT01182168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT02550327. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05738057. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
ClinicalTrials.gov study NCT04861584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT
ClinicalTrials.gov study NCT00246974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00483366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholang
ClinicalTrials.gov study NCT06923475. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Acti
ClinicalTrials.gov study NCT02317419. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00074204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
ClinicalTrials.gov study NCT02944357. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT00627432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
ClinicalTrials.gov study NCT00242190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.